UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006598
Receipt number R000007808
Scientific Title Sivelestat attenuates perioperative inflammatory response in pediatric heart surgery with cardiopulmonary bypass
Date of disclosure of the study information 2011/10/24
Last modified on 2011/10/24 02:14:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Sivelestat attenuates perioperative inflammatory response in pediatric heart surgery with cardiopulmonary bypass

Acronym

Sivelestat attenuates perioperative inflammatory response in pediatric heart surgery with cardiopulmonary bypass:
A prospective randomized study

Scientific Title

Sivelestat attenuates perioperative inflammatory response in pediatric heart surgery with cardiopulmonary bypass

Scientific Title:Acronym

Sivelestat attenuates perioperative inflammatory response in pediatric heart surgery with cardiopulmonary bypass:
A prospective randomized study

Region

Japan


Condition

Condition

congenital heart disease

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Study of sivelestat for perioperative inflammatory response in pediatric heart surgery with cardiopulmonary bypass

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

white blood cell, neutrophil, polymorphonuclear elastase, C-reactive protein, interleukin-6, interleukin-8, tumor necrosis factor alpha

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

The sivelestat group patients are administrated continuous intravenous infusion of 0.2mg/kg/h of sivelestat, and the control group patients are administrated same volume of 0.9% saline at the initiation of CPB to 24h after surgery.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

consecutive heart surgery with cardiopulmonary bypass,
patients are weighting between 5 to 10 kg with

Key exclusion criteria

patients with chromosome aberration were excluded

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nobuyuki Inoue

Organization

Kitasato university shcool of medicine

Division name

cardiovascular surgery

Zip code


Address

Kitasato 1-15-1, Minami, Sagamihara 252-0329, Japan

TEL

042-778-8111

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kitasato university shcool of medicine

Division name

cardiovascular surgery

Zip code


Address


TEL


Homepage URL


Email

nobuyuki-i@goo.jp


Sponsor or person

Institute

kitasato university school of medicine

Institute

Department

Personal name



Funding Source

Organization

department of cardiovascular surgery, kitasato university school of medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 10 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2011 Year 10 Month 24 Day

Date of IRB


Anticipated trial start date

2011 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 10 Month 24 Day

Last modified on

2011 Year 10 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007808


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name